Skip to product information
1 of 6

Prem Inochast-A Dietary Supplement for Women to Support Hormone Balance, Menstrual Cycle and Healthy Ovarian Function

Prem Inochast-A Dietary Supplement for Women to Support Hormone Balance, Menstrual Cycle and Healthy Ovarian Function

Read reviews →
Also see: Amazon · Google · Reddit
Regular price $29.50 USD
Regular price $69.90 USD Sale price $29.50 USD
Sale Sold out
Shipping calculated at checkout.
Quantity

The full picture

Everything Vyvata knows about this product — the score, the evidence, the FAQ, and where else to find shopper reviews. No hidden data. Every vendor is scored on the same published rubric — no brand can pay for placement. Read the rubric →

48/100
Rejected

Six-dimension breakdown

Evidence
45
Formulation
52
Manufacturing
55
Safety
48
Transparency
42
Sustainability
50

Why this scored 48/100

Prem Inochast markets to women for hormone balance, menstrual cycle regularity, ovarian function, and 'symptoms of perimenopause and menopause.' The visible listing describes structure/function claims but does not surface a Supplement Facts panel with per-ingredient doses. Women's hormone-balance botanicals with clinical support include: Vitex agnus-castus (chasteberry) 20-40mg/day for PMS (Ma 2010, Girman 2003); myo-inositol 2-4g/day for PCOS ovulation (Unfer 2016 meta-analysis); DIM 100-200mg for estrogen metabolism modulation. Without knowing what is in this specific formula, and the 'menopause symptoms' language starts to bridge from structure/function into disease-adjacent territory. Standard hormone-support blends often use standardized chasteberry with vitamins B6/B12/folate, but the mixture and doses here are not disclosed. Rejected for the combination of opacity and claim breadth without ingredient-level substantiation.

Last scored: Full rubric →

Evidence & sources

The Vyvata score's Evidence dimension measures the quality of published RCT support for a product's active ingredients at the label dose. Our source hierarchy: double-blind RCTs in MEDLINE-indexed journals > single-blind RCTs > open-label trials > observational studies > mechanism papers > N=1 case studies (anecdotes). Predatory journals and manufacturer-authored studies without independent replication are weighted down.

Product-specific evidence citations for this item are embedded in the analysis text on the "Analysis" tab. For the full framework and evidence hierarchy, see the methodology page.

How to read the Evidence dimension

  • 80–100: Multiple double-blind RCTs in indexed journals directly testing this product OR the exact ingredients at the exact dose.
  • 60–79: Single double-blind RCT + supporting ingredient literature at the studied dose.
  • 40–59: Open-label trials + ingredient literature; no product-specific double-blind evidence.
  • 20–39: Ingredient literature only; no product-specific trials or trials in predatory venues.
  • 0–19: No credible evidence base or unverifiable claims.

FAQ data has not been generated for this product yet. See the site FAQ for general questions.

Customer reviews

Reviews on other platforms

The Vyvata score measures product integrity against a published rubric, not customer sentiment. Vyvata does not aggregate, republish, or license third-party reviews — the links below open search pages on their respective platforms.

All the data we have on this product

Every VSF-related metafield surfaced verbatim. Nothing hidden. If you spot data that looks wrong, let us know.

VSF score
48 / 100
Tier
Rejected
Category
Supplements
Subcategory
womens health
Last scored
Third-party certifications
None on record at time of scoring
Vendor
cotidelle
Product type
Dietary Supplement
Tags
cotidelle, Shopify Collective

Every score is set from the published rubric, audit-logged, and rescored whenever new evidence emerges (published trials, updated labels, third-party testing releases). Every vendor is scored on the same criteria — no pay-to-play. See our editorial-independence disclosure for the full policy, including brands with an editorial relationship to this site.

View full details